ARHGDIA

Chr 17

Rho GDP dissociation inhibitor alpha

Also known as: GDIA1, HEL-S-47e, NPHS8, RHOGDI, RHOGDI-1

This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

ResearchGenerating clinical summary…
DNmechanismLOEUF 0.87
Clinical SummaryARHGDIA
🧬
Gene-Disease Validity (ClinGen)
nephrotic syndrome, type 8 · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 39 VUS of 93 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.87LOEUF
pLI 0.036
Z-score 1.86
OE 0.38 (0.190.87)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.20Z-score
OE missense 0.70 (0.580.83)
87 obs / 124.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.38 (0.190.87)
00.351.4
Missense OE?0.70 (0.580.83)
00.61.4
Synonymous OE?1.57
01.21.6
LoF obs/exp: 4 / 10.5Missense obs/exp: 87 / 124.9Syn Z: -3.35

This gene — mechanism propensity

DN
0.6162th %ile
GOF
0.5170th %ile
LOF
0.2680th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

93 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic1
VUS39
Likely Benign37
Benign3
Conflicting2
4
Pathogenic
1
Likely Pathogenic
39
VUS
37
Likely Benign
3
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
1
0
4
Likely Pathogenic
1
0
0
0
1
VUS
2
37
0
0
39
Likely Benign
1
6
7
23
37
Benign
0
1
2
0
3
Conflicting
2
Total546102386

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 27) ClinVar copy-number / structural variants overlap ARHGDIA — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ARHGDIA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →